Ethanol-responsive genes: Identification of transcription factors and their role in metabolomics

Pharmacogenomics Journal

Volumn 7, Issue 1, 2007, Pages 38-47

  Uddin, R K ^a   Singh, S M ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CIS ACTING ELEMENT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; EPIDERMAL GROWTH FACTOR RECEPTOR 3; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; METALLOTHIONEIN; METALLOTHIONEIN I; METALLOTHIONEIN II; SEROTONIN; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SYNAPTOJANIN; TRANS ACTING FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MAFF; TRANSCRIPTION FACTOR SP1; TRANSCRIPTOME; TRYPTOPHAN HYDROXYLASE; ZINC ION;

ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ALCOHOLISM; APOPTOSIS; ARTICLE; BINDING SITE; BIOINFORMATICS; CELL CYCLE REGULATION; CELL GROWTH; DRINKING BEHAVIOR; DRUNKENNESS; ECOTROPIC VIRUS; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENE TARGETING; GENETIC ANALYSIS; GENETIC REGULATION; HOMEOSTASIS; HUMAN; METABOLOMICS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MOTIF; SIGNAL TRANSDUCTION; VIRUS DNA CELL DNA INTERACTION;

CELL CYCLE; CENTRAL NERVOUS SYSTEM DEPRESSANTS; COMPUTER SIMULATION; ETHANOL; GENES; HOMEOSTASIS; MODELS, GENETIC; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; ZINC;

EID: 33847304540     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500394     Document Type: Article

References (73)

1. Crabbe JC. Genetic contributions to addiction. Annu Rev Psychol 2002; 53: 435-462.
2. Ryabinin AE. Role of hippocampus in alcohol-induced memory impairment: implications from behavioral and immediate early gene studies. Psychopharmacology (Berlin) 1998; 139: 34-43.
3. Torres G, Horowitz JM. Individual and combined effects of ethanol and cocaine on intracelleilar signals and gene expression. Prog Neuropsychopharmacol Biol Psychiatry 1996; 20: 561-596.
4. Fan L, Bellinger F, Ge YL, Wilce P. Genetic study of alcoholism and novel gene expression in the alcoholic brain. Addict Biol 2004; 9: 11-18.
5. Lewohl JM, Wang L, Miles MF, Zhang L, Dodd PR, Harris RA. Gene expression in human alcoholism: Microarray analysis of frontal cortex. Alcohol Clin Exp Res 2000; 24: 1873-1882.
6. Mayfield RD, Lewohl JM, Dodd PR, Herlihy A, Liu J, Harris RA. Patterns of gene expression are altered in the frontal and motor cortices of human alcoholics. J Neurochem 2002; 81: 802-813.
7. Murphy BC, Chiu T, Harrison M, Uddin RK, Singh SM. Examination of ethanol responsive liver and brain specific gene expression, in the mouse strains with variable ethanol preferences, using cDNA expression arrays. Biochem Genet 2002; 40: 395-410.
8. Treadwell JA, Singh SM. Microarray analysis of mouse brain gene expression following acute ethanol treatment. Neurochem Res 2004; 29: 357-369.
9. Uddin RK, Treadwell JA, Singh SM. Towards unraveling ethanol-specific neuro-metabolomics based on ethanol responsive genes in vivo. Neurochem Res 2005; 30: 1179-1190.
10. Michelson AM. Deciphering genetic regulatory codes: A challenge for functional genomics. Proc Natl Acad Sci USA 2002; 99: 546-548.
11. Remenyi A, Scholer HR, Wilmanns M. Combinatorial control of gene expression. Nat Struct Mol Biol 2004; 11: 812-815.
12. Smith IL, Freebern WJ, Collins I, De Siervi A, Montano I, Haggerty CM et al. Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitment Proc Natl Acad Sci USA 2004; 101: 11554-11559.
13. Seifert M, Scherf M, Epple A, Werner T. Multievidence microarray mining. Trends Genet 2005; 21: 553-558.
14. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A et al. MatInspector and beyond: Promoter analysis based on transcription factor binding sites. Bioinformatics 2005; 21: 2933-2942.
15. Korkalainen M, Linden J, Tuomisto J, Pohjanvirta R. Effect of TCDD on mRNA expression of genes ecoding bHLH/PAS proteins in rat hypothalamus. Toxicology 2005; 208: 1-11.
16. Tsuchiya Y, Nakajima M, Itoh S, Iwanari M, Yokoi T. Expression of aryl hydrocarbon receptor repressor in normal human tissues and inducibility by polycyclic aromatic hydrocarbons in human tumor-derived cell lines. Toxicol Sci 2003; 72: 253-259.
17. Soneda S, Fukami M, Fujimoto M, Hasegawa T, Koitabashi Y, Ogata T. Association of micropenis with Pro185Ala polymorphism of the gene for aryl hydrocarbon receptor repressor involved in dioxin signaling. Endocr J 2005; 52: 83-88.
18. Evans BR, Karchner SI, Franks DG, Hahn ME. Duplicate aryl hydrocarbon receptor repressor genes (ahrr1 and ahrr2) in the zebrafish Danio rerio: structure, function, evolution, and AHR-dependent regulation in vivo. Arch Biochem Biophys 2005; 441: 151-167.
19. Miller IJ, Bieker JJ. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins. Mol Cell Biol 1993; 13: 2776-2786.
20. Drissen R, von Lindern M, Kolbus A, Driegen S, Steinlein P, Beug H et al. The erythroid phenotype of EKLF-null mice: Defects in hemoglobin metabolism and membrane stability. Mol Cell Biol 2005; 25: 5205-5214.
21. Chen X, Bieker JJ. Stage-specific repression by the EKLF transcriptional activator. Mol Cell Biol 2004; 24: 10416-10424.
22. Verstreken P, Koh TW, Schulze KL, Zhai RG, Hiesinger PP, Zhou Y et al. Synaptojanin is recruited by endophilin to promote synaptic vesicle uncoating. Neuron 2003; 40: 733-748.
23. Stopkova P, Vevera J, Paclt I, Zukov I, Lachman HM. Analysis of SYNJ1, a candidate gene for 21q22 linked bipolar disorder: A replication study. Psychiatr Res 2004; 127: 157-161.
24. Saito T, Guan F, Papolos DF, Lau S, Klein M, Fann CS et al. Mutation analysis of SYNJ1: A possible candidate gene for chromosome 21q22-linked bipolar disorder. Mol Psychiatr 2001; 6: 387-395.
25. Hamon M, Bourgoin S, Artaud F, El Mestikawy S. The respective roles of tryptophan uptake and tryptophan hydroxylase in the regulation of serotonin synthesis in the central nervous system. J Physiol (Paris) 1981; 77: 269-279.
26. Malhotra AK, Murphy Jr GM, Kennedy JL. Pharmacogenetics of psychotropic drug response. Am J Psychiatr 2004; 161: 780-796.
27. Wong AH, Van Tol HH. The dopamine D4 receptors and mechanisms of antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatr 2003; 27: 1091-1099.
28. Gorwood P, Lanfumey L, Hamon M. Alcohol dependence and polymorphisms of serotonin-related genes. Med Sci (Paris) 2004; 20: 1132-1138.
29. Johnson BA. An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence. Expert Opin Pharmacother 2004; 5: 1943-1955.
30. McBride WJ, Lovinger DM, Machu T, Thielen RJ, Rodd ZA, Murphy JM et al. Serotonin-3 receptors in the actions of alcohol, alcohol reinforcement, and alcoholism. Alcohol Clin Exp Res 2004; 28: 257-267.
31. Zill P, Buttner A, Eisenmenger W, Moller HJ, Ackenheil M, Bondy B. Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: A post-mortem study. J Psychiatr Res 2005; in press [Epub ahead of print].
32. Lai TJ, Wu CY, Tsai HW, Lin YM, Sun HS. Polymorphism screening and haplotype analysis of the tryptophan hydroxylase gene (TPH1) and association with bipolar affective disorder in Taiwan. BMC Med Genet 2005; 6: 14.
33. Sun HS, Fann CS, Lane HY, Chang YT, Chang CJ, Liu YL et al. A functional polymorphism in the promoter region of the tryptophan hydroxylase gene is associated with alcohol dependence in one aboriginal group in Taiwan. Alcohol Clin Exp Res 2005; 29: 1-7.
34. Nielsen DA, Virkkunen M, Lappalainen J, Eggert M, Brown GL, Long JC et al. A tryptophan hydroxylase gene marker for suicidality and alcoholism. Arch Gen Psychiatr 1998; 55: 593-602.
35. Paik I, Toh K, Kim J, Lee C. TPH gene may be associated with suicidal behavior, but not with schizophrenia in the Korean population. Hum Hered 2000; 50: 365-369.
36. Chung IW, Kim H, Sribney W, Hong JB, Lee CH, Lee KY et al. Tryptophan hydroxylase polymorphism is associated with age of onset of alcoholism related behaviors. Alcohol 2005; 36: 1-3.
37. Loney KD, Uddin KR, Singh SM. Strain-specific brain metallothionein II (MT-II) gene expression, its ethanol responsiveness, and association with ethanol preference in mice. Alcohol Clin Exp Res 2003; 27: 388-395.
38. Heuchel R, Radtke F, Georgiev O, Stark G, Aguet M, Schaffner W. The transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expression. EMBO J 1994; 13: 2870-2875.
39. Solis WA, Childs NL, Weedon MN, He L, Nebert DW, Dalton TP. Retrovirally expressed metal response element-binding transcription factor-1 normalizes metallothibnein-1 gene expression and protects cells against zinc, but not cadmium, toxicity. Toxicol Appl Pharmacol 2002; 178: 93-101.
40. Wang Y, Wimmer U, Lichtlen P, Inderbitzin D, Stieger B, Meier PJ et al. Metal-responsive transcription factor-1 (MTF-1) is essential for embryonic liver development and heavy metal detoxification in the adult liver. FASEB J 2004; 18: 1071-1079.
41. Guerrerio AL, Berg JM. Metal ion affinities of the zinc finger domains of the metal responsive element-binding transcription factor-1 (MTF1). Biochemistry 2004; 43: 5437-5444.
42. Bi Y, Palmiter RD, Wood KM, Ma Q. Induction of metallothionein I by phenolic antioxiclants requires metal-activated transcription factor 1 (MTF-1) and zinc. Biochem J 2004; 380: 695-703.
43. Pandey SC, Chartoff EH, Carlezon Jr WA, Zou J, Zhang H, Kreibich AS et al. CREB gene transcription factors: Role in molecular mechanisms of alcohol and drug addiction. Alcohol Clin Exp Res 2005; 29: 176-184.
44. Asher O, Cunningham TD, Yao L, Gordon AS, Diamond I. Ethanol stimulates cAMP-responsive element (CRE)-mediated transcription via CRE-binding protein and cAMP-dependent protein kinase. J Pharmacol Exp Ther 2002; 301: 66-70.
45. Constantinescu A, Gordon AS, Diamond I. cAMP-dependent protein kinase types I and II differentially regulate cAMP response element-mediated gene expression: Implications for neuronal responses to ethanol. J Biol Chem 2002; 277: 18810-18816.
46. Yang X, Diehl AMW, Wand GS. Ethanol exposure alters the phosphorylation of cyclic AMP responsive element binding protein and cyclic AMP responsive element binding activity in rat cerebellum. J Pharmacol Exp Ther 1996; 278: 338-346.
47. Pandey SC, Mittal N, Lumeng L, Li TK. Involvement of the cyclic AMP-responsive element binding protein gene transcription factor in genetic preference for alcohol drinking behavior. Alcohol Clin Exp Res 1999; 23: 1425-1434.
48. Misra K, Pandey SC. Differences in basal levels of CREB and NPY in nucleus accumbens regions between C57BL/6 and DBA/2 mice differing in inbom alcohol drinking behavior. J Neurosci Res 2003; 74: 967-975.
49. Yamaguchi-Shinozaki K, Shinozaki K. Organization of cis-acting regulatory elements in osmotic- and cold-stress-responsive promoters. Trends Plant Sci 2005; 10: 88-94.
50. Kleinjan DA, van Heyningen V. Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet 2005; 76: 8-32.
51. Klingenhoff A, Frech K, Quandt K, Werner T. Functional promoter modules can be detected by formal models independent of overall nucleoticle sequence similarity. Bioinformatics 1999; 15: 180-186.
52. Yatsula B, Lin S, Read AJ, Poholek A, Yates K, Yue D et al. Identification of binding sites of EVI1 in mammalian cells. J Biol Chem 2005; 280: 30712-30722.
53. Alliston TN, Maiyar AC, Buse P, Firestone GL, Richards JS. Follicle stimulating hormone-regulated expression of serum/ glucocorticoid-inducible kinase in rat ovarian granulosa cells: A functional role for the Sp1 family in promoter activity. Mol Endocrinol 1997; 11: 1934-1949.
54. Savickiene J, Treigyte G, Magnusson KE, Navakauskiene R. p2l (Waf1/Cip1) and FasL gene activation via Sp1 and NFkappaB is required for leukemia cell survival but not for cell death induced by diverse stimuli. Int J Biochem Cell Biol 2005; 37: 784-796.
55. Savickiene J, Treigyte G, Pivoriunas A, Navakauskiene R, Magnusson KE. Sp1 and NF-kappaB transcription factor activity in the regulation of the p21 and FasL promoters during promyelocytic leukemia cell monocytic differentiation and its associated apoptosis. Ann NY Acad Sci 2004; 1030: 569-577.
56. Vaque IP, Navascues J, Shiio Y, Laiho M, Ajenjo N, Mauleon I et al. Myc antagonizes Ras-mediated growth arrest in leukemia cells through the inhibition of the Ras-ERK-p21Cip1 pathway. J Biol Chem 2005; 280: 1112-1122.
57. Sakaguchi M, Miyazaki M, Takaishi M, Sakaguchi Y, Makino E, Kataoka N et al. S100C/A11 is a key mediator of Ca(2+)-induced growth inhibition of human epidermal keratinocytes. J Cell Biol 2003; 163: 825-835.
58. Chowdhury IH, Farhadi A, Wang XF, Robb ML, Birx DL, Kim JH. Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2. Int J Cancer 2003; 107: 603-611.
59. Coqueret O, Gascan H. Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SDI1. J Biol Chem 2000; 275: 18794-18800.
60. Kawasaki H, Eckner R, Yao TP, Taira K, Chiu R, Livingston DM et al. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature 1998; 393: 284-289.
61. Tagliabracci CE, Singh SM. Genetic regulation of gene-specific mRNA by ethanol in vivo and its possible role in ethanol preference in a cross with RI lines in mice. Biochem Genet 1996; 34: 219-238.
62. Chen CC, Lu RB, Chen YC, Wang MF, Chang YC, Li TK et al. Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism. Am J Hum Genet 1999; 65: 795-807.
63. Vasiliou V, Pappa A. Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease. Pharmacology 2000; 61: 192-198.
64. Jornvall H, Hoog JO, Persson BPares X. Pharmacogenetics of the alcohol dehydrogenase system. Pharmacology 2000; 61: 184-191.
65. Whitfield JB. Alcohol and gene interactions. Clin Chem Lab Med 2005; 43: 480-487.
66. Koob GF, Roberts AJ, Schulteis G, Parsons LH, Heyser CJ, Hyytia P et al. Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin Exp Res 1998; 22: 3-9.
67. Oscar-Berman M, Shagrin B, Evert DL, Epstein C. Impairments of brain and behavior: The neurological effects of alcohol. Alcohol Health Res World 1997; 21: 65-75.
68. Bowirrat A, Oscar-Berman M. Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome. Am J Med Genet B Neuropsychiatr Genet 2005; 132: 29-37.
69. Heidbreder CA, Andreoli M, Marcon C, Thanos PK, Ashby Jr CR, Gardner EL. Role of dopamine D3 receptors in the addictive properties of ethanol. Drugs Today (Barc) 2004; 40: 355-365.
70. Uddin RK, Singh SM. The effect of ethanol may be realized via the cis-regulatory sequences of the genes involved in apoptosis, cell growth and proliferation. Mol Brain Res 2006 (in Press).
71. Elkon R, Linhart C, Sharan R, Shamir R, Shiloh Y. Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. Genome Res 2003; 13: 773-780.
72. Fessele S, Maier H, Zischek C, Nelson PJ, Werner T. Regulatory context is a crucial part of gene function. Trends Genet 2002; 18: 60-63.
73. Kel A, Kel-Margoulis O, Babenko V, Wingender E. Recognition of NFATp/AP-1 composite elements within genes induced upon the activation of immune cells. J Mol Biol 1999; 288: 353-376.